Fujian Wanchen Biotechnology Co.,Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Fujian Wanchen Biotechnology Co.,Ltd - overview
Established
2011
Location
Zhangzhou, Fujian, China
Primary Industry
Agribusiness
About
Based in Zhangzhou, China and established in 2011, Fujian Wanchen Biotechnology Co. ,Ltd is an provider that focuses on edible mushroom. In 2012, the company changed its name from Fujian Mimosa Biotechnology to Fujian Wanchen Biotechnology Co. ,Ltd.
In 2013, the company established a subsidiary called Nanjing Jinwanchen Biotechnology. The company engages in the development of edible mushroom. Its main products include enoki mushroom, crab-flavored mushroom, white jade mushroom and seafood mushroom, etc. The company's products are sold to China, Southeast Asia, Europe and the United States and other regions.
Current Investors
Huatai Securities, Shenzhen Zhongmin Capital, Red Bridge Capital
Primary Industry
Agribusiness
Sub Industries
Canned/Frozen Fruit & Vegetables, Crop Production
Website
www.vanchen.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Fujian Wanchen Biotechnology Co.,Ltd - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 246,715,366.3 | 342,722,302.1 | 450,909,279.2 | 449,885,926.1 | 425,520,717.9 | - | - | - |
| % Revenue Growth (YoY) | - | 38.9% | 31.6% | (0.2%) | (5.4%) | - | - | - |
| EBITDA (USD) | 57,248,824.6 | 85,923,379 | 152,936,259.4 | 163,536,230.6 | 91,698,620.2 | - | - | - |
| Operating Income (USD) | 16,517,424.6 | 34,845,079 | 93,458,959.4 | 103,930,472.5 | 30,415,426.3 | - | - | - |
| Operating Margin | 6.7% | 10.2% | 20.7% | 23.1% | 7.1% | - | - | - |
| % EBITDA Margin | 23.2% | 25.1% | 33.9% | 36.4% | 21.5% | - | - | - |
| NET Income (USD) | 16,482,735.7 | 34,738,158.6 | 92,187,595.4 | 96,130,282.5 | 24,279,165.3 | - | - | - |
| % Net Margin | 6.7% | 10.1% | 20.4% | 21.4% | 5.7% | - | - | - |
Fujian Wanchen Biotechnology Co.,Ltd - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Announced | Nanjing Zhongcheng Information Technology Co., Ltd. | - | ||||||||
| Add-on | Completed | Nanjing Wanyou | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.